ZVRA ▼ -9.9% - Zevra Therapeutics, Inc.
$ZVRA - Zevra Therapeutics Announces Final CHMP Opinion on Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union
13-NOV-2026 06:26 AM ET
Share this post
More filings for $ZVRA
ZVRA - Zevra Therapeutics, Inc. - SEC Filing Update (05-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 5, 2026ZVRA ▲ +1.6% - Zevra Therapeutics, Inc.Nov 3, 2026ZVRA ▼ -0.5% - Zevra Therapeutics, Inc.Oct 20, 2026ZVRA ▼ -1.7% - Zevra Therapeutics, Inc.Sep 2, 2026ZVRA - Zevra Therapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 6, 2026$ZVRA SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 31, 2026
View full $ZVRA filing history →💬 Comments
Loading comments…
Leave a comment